BCRB 2018

19/09/2018

EGFR expression & prognosis

DAHANCA 6 and 7

HR 0.62

HNSCC with high EGFr expression respond better to moderately accelerated radiotherapy than tumors with low EGFr

HR 0.70

Eriksen Radiother Oncol 2005

EGFR expression & prognosis

HNSCC with high EGFr and well/moderate differentiation benefit from moderately accelerated radiotherapy regarding LR control

HR 0.54

Such effect was not seen in tumors with low EGFr and/or poor differentiation

Eriksen Radiother Oncol 2005

5